Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wrist surgery pain breakthrough? lower anesthetic dose may ease rebound pain

NCT ID NCT06950372

Symptom relief Sponsor: Oslo University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 80 adults having wrist fracture surgery to see if a lower concentration of the local anesthetic ropivacaine (3.75 mg/ml vs. 7.5 mg/ml) in a nerve block affects the severity of pain when the block wears off. Participants were randomly assigned to one of the two doses and reported their pain levels and medication use for up to 6 weeks after surgery. The goal is to find the best dose to minimize rebound pain while still providing good pain control during the operation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ropivacaine
What this could lead to
If it works, this could help doctors choose the best dose of local anesthetic to reduce severe pain after wrist surgery.
What could go wrong
This is a small, completed trial with only 80 participants. The results may not apply to everyone, and the lower dose might not control pain as well during surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

80 people

The number who actually took part.

Started

Feb 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with distal radius fracture, scheduled for volar plate surgery * Surgery up to 20 days after fracture trauma * 18 to 80 years old (inclusive) * ASA 1, 2 or stable ASA 3 * Body Mass Index (BMI) 18 to 40 kg/m2 (inclusive) * Weight of 50 kg or more * Ability to communicate sufficiently in a scandinavian language * Capable of giving a signed informed consent * Ability and willingness to understand og be compliant to the study Exclusion Criteria: * Contemporaneous painful injuries * Existing long-term pain * Peripheral nerve damage in the arm with radius fracture * Patients who prior to fracture trauma use opioids, psycothropic drugs or medication, with or without prescription, with significantly sedative effect on regular basis. * Excessive use of alcohol (more than 15 units of alchol per week for men, more than 8 units of alchol per week for women, or patients reporting to be incapable of avoiding alcohol as long as they use strong opioids). * Progressive neurologic disease (inclusive diabetic neuropathy). * Skin infection at the site for brachial plexus nerve block * Other contraindications for brachial plexus nerve block * Contraindications for ropivacaine, paracetamol, etoricoxib, dexamehtasone or oxycodone * Previous allergic reaction to local anaesthetics or etoricoxib, dexamethasone, oxycodone or paracetamol. * Pregnant or breast-feeding women at surgery day (they do not get excluded if they become pregnant in the follow up period after intervention and surgery)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Radius fracture distal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

radius fracture Wrist Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Radius fracture distal Rebound pain

Contacts and locations

Locations

  • Oslo University Hospital

    Oslo, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.